Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Cash from Operations (2020 - 2026)

Immuneering's Cash from Operations history spans 7 years, with the latest figure at 18433444.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations fell 30.91% to 18433444.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 49697401.0, a 7.26% increase, with the full-year FY2025 number at 45344595.0, up 17.55% from a year prior.
  • Cash from Operations came in at 18433444.0 for Q1 2026, down from 9840598.0 in the prior quarter.
  • The five-year high for Cash from Operations was 9446124.0 in Q2 2025, with the low at 18433444.0 in Q1 2026.
  • Historically, Cash from Operations has averaged 12461618.18 across 5 years, with a median of 11977235.0 in 2025.
  • Biggest five-year swings in Cash from Operations: tumbled 100.02% in 2022 and later soared 32.18% in 2025.
  • Year by year, Cash from Operations stood at 11748614.0 in 2022, then dropped by 0.23% to 11775201.0 in 2023, then decreased by 23.23% to 14510513.0 in 2024, then soared by 32.18% to 9840598.0 in 2025, then plummeted by 87.32% to 18433444.0 in 2026.
  • Business Quant data shows Cash from Operations for IMRX at 18433444.0 in Q1 2026, 9840598.0 in Q4 2025, and 11977235.0 in Q3 2025.